Cargando…

Editorial: PROTACs: Targeted therapies for cancer treatment

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Tabassum, Sobia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936187/ https://www.ncbi.nlm.nih.gov/pubmed/36819095 http://dx.doi.org/10.3389/fcell.2023.1102721

Ejemplares similares

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2022)

PROTACs: The Future of Leukemia Therapeutics
por: Anwar, Zubair, et al.
Publicado: (2022)

Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022)

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
por: Juan, Alberto, et al.
Publicado: (2022)

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
por: Liu, Jing, et al.
Publicado: (2021)

Editorial: Targeted therapies for aggressive cancers
por: Lee, Sean B., et al.
Publicado: (2023)

Editorial: Cell Death and Targeted Cancer Therapies
por: Bagci-Onder, Tugba, et al.
Publicado: (2022)

Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologies
por: Sousa, Ângela, et al.
Publicado: (2023)

Editorial: The adipose tissue microenvironment in cancer: Molecular mechanisms and targets for treatment
por: Yang, Yunlong
Publicado: (2022)

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Editorial: Tumor microenvironment and cancer therapy
por: Xie, Yi, et al.
Publicado: (2023)

Editorial: Kinase inhibitors in cancer therapy
por: Yadav, Dharmendra Kumar
Publicado: (2022)

Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors
por: Feng, Haoran, et al.
Publicado: (2023)

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance
por: Patel, Girijesh Kumar, et al.
Publicado: (2023)

Editorial: Targeting Lipid Rafts as a Strategy Against Infection and Cancer
por: Garofalo, Tina, et al.
Publicado: (2021)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Editorial: Targeting Heterogeneity of Mesenchymal Stem Cells
por: Zhang, Qi, et al.
Publicado: (2022)

Editorial: Targeting Developmental Pathways in Inflammation and Disease
por: Anastasiadou, Eleni, et al.
Publicado: (2021)

Editorial: Cell therapy, liver diseases, and regeneration
por: Zhang, Wencheng, et al.
Publicado: (2022)

Editorial: Targeting Dysregulated Inflammation to Treat Cardiovascular Diseases
por: Buelna-Chontal, Mabel, et al.
Publicado: (2022)

Editorial: Nanomaterials for targeted delivery of therapeutic and imaging agents
por: Chockalingam, S., et al.
Publicado: (2022)

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
por: Ruocco, Maria Rosaria, et al.
Publicado: (2022)

Editorial: Skeletal muscle—From developmental concepts to therapy
por: Dietrich, Susanne, et al.
Publicado: (2023)

Editorial: Tissue Engineering and Cell Therapy for Cartilage Restoration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2022)

Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine
por: Pützer, Brigitte M., et al.
Publicado: (2022)

Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017)

On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
por: Teixeira, Adilson Fonseca, et al.
Publicado: (2020)

Editorial: Extracellular Vesicles: From Characterization to Treatment
por: Li, Xinlei, et al.
Publicado: (2022)

Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023)

Targeting Integrins for Cancer Therapy - Disappointments and Opportunities
por: Bergonzini, Cecilia, et al.
Publicado: (2022)

Editorial: Biophysical target engagement assays in chemical biology and pharmacological research
por: Baljinnyam, Bolormaa, et al.
Publicado: (2023)

Editorial: The Vascular Niche in Tissue Repair: A Therapeutic Target for Regeneration
por: Rivera, Francisco J., et al.
Publicado: (2017)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Editorial: Epigenetic Reprogramming and Cancer Development
por: Brown, Geoffrey, et al.
Publicado: (2020)

Editorial: Metabolism and Cell Adhesion in Cancer
por: Hartmann, Tanja Nicole
Publicado: (2022)

Editorial: Molecular Mechanisms of Autophagy in Cancer
por: Humbert, Magali, et al.
Publicado: (2022)

Editorial: The Use of Organoids in Cancer Biology
por: Xue, Xiang, et al.
Publicado: (2022)

Editorial: Cellular reprogramming in development, disease, and design of cell-replacement therapies
por: Burke, Zoë D., et al.
Publicado: (2023)

Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research
por: Hernandez, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4qnrpt1idmcq96sbhgmoj7gin